IP Library Granted Patent US 7,585,650
Granted Patent B2
US 7,585,650 · App. 11/790,063 · Granted Sep 8, 2009

Alleles of the zwf gene from coryneform bacteria

Assignee: Degussa AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,585,650
App. No.
11/790,063
Granted
Sep 8, 2009
Kind
B2
Abstract

The invention relates to mutants and alleles of the zwf gene of coryneform bacteria, which encode variants of the Zwf subunit of glucose 6-phosphate dehydrogenase (EC: 1.1.1.49), and to processes for preparing amino acids, in particular L-lysine and L-tryptophan, by using bacteria which harbor said alleles.

Claims (25)

1. An isolated polynucleotide encoding a polypeptide of coryneform bacteria having glucose 6-phosphate dehydrogenase enzyme activity, wherein said polypeptide comprises the amino acid sequence of SEQ ID NO:2, except that any proteinogenic amino acid other than glycine is present at position 321 and/or any proteinogenic amino acid other than serine is present at position 8.

2. The isolated polynucleotide of claim 1 , wherein said isolated polynucleotide comprises the nucleotide sequence of SEQ ID NO:1, except that the codon for the amino acid in position 321 of the protein encoded is for any proteinogenic amino acid other than glycine and/or the codon for the amino acid at position 8 is for any proteinogenic amino acid other than serine.

3. The isolated polynucleotide of claim 1 , wherein, except for the amino acids at positions 321 and 8, said polypeptide consists of the amino acid sequence of SEQ ID NO:2.

4. The isolated polynucleotide of claim 1 , wherein said polypeptide is 514 amino acids in length.

5. The isolated polynucleotide of claim 1 , wherein the amino acid at position 321 of said polypeptide is L-serine.

6. The isolated polynucleotide of claim 1 , wherein the amino acid at position 8 of said polypeptide is L-threonine.

7. The isolated polynucleotide of claim 1 , wherein the amino acid at position 321 of said polypeptide is L-serine and the amino acid at position 8 of said polypeptide is L-threonine.

8. The isolated polynucleotide of claim 1 , wherein said isolated polynucleotide comprises the nucleotide sequence of SEQ ID NO:5, SEQ ID NO:7 or SEQ ID NO:9.

9. The isolated polynucleotide of claim 1 , wherein said isolated polynucleotide comprises the nucleotide sequence of SEQ ID NO:11.

10. A vector comprising the nucleotide sequence of the isolated polynucleotide of claim 1 .

11. An isolated coryneform bacterium comprising a polynucleotide sequence encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:2 except that any proteinogenic amino acid other than glycine is present at position 321 and/or any proteinogenic amino acid other than serine is present at position 8, and wherein said polypeptide has glucose 6-phosphate dehydrogenase activity.

12. The isolated coryneform bacterium of claim 11 , wherein said polypeptide comprises an amino acid sequence having a length of 514 amino acids.

13. The isolated coryneform bacterium of claim 12 , wherein said isolated coryneform bacterium is selected from the group consisting of Corynebacterium efficiens, Corynebacterium glutamicum, Corynebacterium thermoaminogenes and Corynebacterium aminogenes.

14. A process for preparing an L-amino acid, comprising:

a) fermenting a coryneform bacterium in a suitable medium, said coryneform bacterium comprising the isolated polynucleotide of claim 1 ;

b) concentrating the L-amino acid in the fermentation broth or in the cells of said bacterium.

15. The process of claim 14 , wherein said polypeptide comprises an amino acid sequence having a length of 514 amino acids.

16. The process of claim 14 , wherein said L-amino acid is purified from the fermentation broth or cells of step b).

17. The process of claim 14 , further comprising:

c) concentrating said L-amino acid in said fermentation broth in step b, collecting said fermentation broth and then removing an amount of from 0 to 100% of the biomass present; and

d) preparing from the composition produced in step c, an essentially dry and shaped product by a method selected from the group consisting of granulation, compacting, spray drying and extrusion.

18. The process of claim 17 , wherein the essentially dry and shaped product obtained in step d) is sprayed with an oil.

19. The process of claim 14 , wherein said L-amino acid is either L-lysine or L-tryptophan.

20. The vector of claim 10 , wherein, except for the amino acids at positions 321 and 8, said polypeptide consists of the amino acid sequence of SEQ ID NO:2.

21. A coryneform bacterium comprising the vector of claim 20 .

Assignments (4)
CHANGE OF NAME Recorded Feb 1, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051776/0641 →
CHANGE OF NAME Recorded Feb 23, 2010
From: DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 024006/0127 →
CHANGE ADDRESS Recorded Feb 22, 2010
From: EVONIK DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 023985/0296 →
CHANGE OF ENTITY Recorded Feb 22, 2010
From: DEGUSSA AG
To: DEGUSSA GMBH
Reel/Frame 023998/0937 →
Priority Claims (1)
DE 10 2005 013 676 · Mar 24, 2005 · national
Continuity (3)
Division 1128441600 · Nov 22, 2005
Provisional Application 6070909400 · Aug 18, 2005
Related Publication 20070224666A1 · Sep 27, 2007